CD8A and cancer: A more recent study performed on 12 different types of cancer established that around the 70% and 21% of patients were showing respectively partial and complete responses since they were displaying defect in the DNA damage repair (DDR) machinery and the expansion of TSA specific CD8 T cell-clones was observed in ICB responder patient (42).